Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665238 | SCV000789327 | likely pathogenic | Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency | 2017-01-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001851758 | SCV002236481 | pathogenic | Mitochondrial trifunctional protein deficiency; Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency | 2021-08-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 8729). This variant is also known as Q342Stop. This premature translational stop signal has been observed in individual(s) with clinical features of long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (PMID: 7846063, 28559085). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln378*) in the HADHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HADHA are known to be pathogenic (PMID: 7738175, 21103935, 21549624, 22459206). |
OMIM | RCV000009268 | SCV000029486 | pathogenic | Mitochondrial trifunctional protein deficiency | 1995-01-31 | no assertion criteria provided | literature only |